KLP Kapitalforvaltning’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$921K Buy
32,300
+21,500
+199% +$468K ﹤0.01% 1177
2026
Q1
$187K Hold
10,800
﹤0.01% 1838
2025
Q4
$203K Buy
10,800
+1,100
+11% +$18.4K ﹤0.01% 1835
2025
Q3
$141K Hold
9,700
﹤0.01% 1954
2025
Q2
$190K Hold
9,700
﹤0.01% 1810
2025
Q1
$172K Hold
9,700
﹤0.01% 1813
2024
Q4
$208K Buy
+9,700
New +$236K ﹤0.01% 1806

Other funds holding CDNA

KLP Kapitalforvaltning's CDNA Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its CareDx (CDNA) stake by 199% in Q2 2026, buying an estimated $468K and bringing the position to 32,300 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

KLP Kapitalforvaltning first reported a position in CDNA in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • KLP Kapitalforvaltning held 32,300 shares of CareDx worth $921K as of Q2 2026.
  • KLP Kapitalforvaltning bought 21,500 CareDx shares in Q2 2026, an estimated $468K.
  • CareDx made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1177 holding.
  • KLP Kapitalforvaltning first reported a position in CareDx in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.